18 participants
A Phase I, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of BP2202 in Patients With Relapsed/Refractory Multiple Myeloma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-10
- Start Date:
- 2026-10-01
- Completion:
- 2027-12-31
Conditions
- Relapsed/Refractory Multiple Myeloma (RRMM)
Interventions
- BIOLOGICAL
No Results Yet